Dare Bioscience, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2016 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Dare Bioscience, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2016 to Q2 2022.
  • Dare Bioscience, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2022 was $10M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $10M Jun 30, 2022 10-Q 2022-08-09
Q4 2021 $0 Dec 31, 2021 10-Q 2022-08-09
Q1 2017 $1.14M Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $823K Dec 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.